“…Because of the gut-liver circulation via the gut-microbiota-liver axis, nutrients, bacterial products/toxins and metabolites from the gut enters the liver, which play important roles in the progression of liver disease (Wiest et al, 2017). Previous studies indicate that compositional changes of the gut microbiota are closely related to chronic liver diseases, such as non-alcoholic fatty liver disease (NAFLD) (Bibbò et al, 2018;Hoyles et al, 2018;Ponziani et al, 2018), non-alcoholic steatohepatitis (NASH) (Yamada et al, 2017;Bomhof et al, 2018;Ye et al, 2018), alcoholic liver disease (ALD) (Hartmann et al, 2018;Shao et al, 2018;Stärkel et al, 2018), hepatic encephalopathy (HE) (Tilg et al, 2016;Mancini et al, 2018), cirrhosis (Garcia-Tsao and Wiest, 2004;Bajaj et al, 2018a;Guo et al, 2018), hepatocellular carcinoma (HCC) (Zamparelli et al, 2017), and HBV infection. Increasing evidence suggests that the gut microbiota has evolved as a new important player in the pathogenesis of hepatitis B virus-induced chronic liver disease.…”